• Skip to primary navigation
  • Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Case reports
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • BC Issues until 2024
  • Submission
  • Istruction for authors
  • Search

CASI CLINICI – Case Reports

Volume:

Biochimica Clinica 2013; 37(5) 431-434

Published on-line:

DOI:

Download in PDF:
Authentication required

Componenti monoclonali piccole ma dannose

AUTHORS

Paolo Milani1, Giovanni Palladini1, Maria Stella Graziani1,2, Giampaolo Merlini1
1Area di Ricerca di Biotecnologie e Laboratorio di Analisi Chimico Cliniche, Fondazione IRCCS Policlinico San Matteo, Dipartimento di Medicina Molecolare, Università di Pavia
2Azienda Ospedaliera Universitaria di Verona

ABSTRACT

Small but harmful monoclonal components

A small B-cell clone can synthesize a toxic monoclonal protein that causes severe organ damage. Diseases caused by these toxic immunoglobulins range from AL amyloidosis, light chain deposition disease and cryoglobulinemia to the POEMS (Polineuropathy, Organomegaly, Endocrinopathy, Monoclonal protein and Skin changes) syndrome. The serum monoclonal components are, in these cases, usually small and difficult to be detected by the commercially available methods. However, an early detection and a correct characterization of the monoclonal component is essential, because misdiagnosis or a delay in diagnosis can prevent the proper treatment of the patient worsening his outcome. Here we present two cases of amyloidosis AL, where the correct diagnosis was facilitated by specific and sensitive techniques. This does not mean that every clinical laboratory should be competent in this field and use these methods routinely, but simply that people should be aware of the problem, so that these clinical conditions can be properly managed.

REFERENCES